MP Group – AI toolkit for early-stage drug discovery
Early this year, we shared an outlook giving an overview of the role of Artificial Intelligence in Drug Discovery. Through our conversations with several global pharma and biotechs, we realized that, while the enthusiasm around the potential of AI is high, a shadow of skepticism looms over. A common theme in our dialogs was on explaining the advantages of AI-based interventions over the traditional methods and what to expect out of AI-based platforms. To help build a deeper perspective on AI…